Strategy Asset Managers’s Humana HUM Stock Holding History

Strategy Asset Managers’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,429	Closed	-$663K	–	263
2021 Q4	$663K	Sell	1,429 -140	-9%	-$62K	0.17%	107
2021 Q3	$611K	Buy	+1,569	New	+$666K	0.14%	139

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Strategy Asset Managers's HUM Position: Q1 2022 in Review

Strategy Asset Managers sold out of Humana (HUM) in Q1 2022, closing a stake of 1,429 shares — an estimated $663K sold.

Strategy Asset Managers first reported a position in HUM in Q3 2021 and held it in 2 quarters. The position peaked at $663K in Q4 2021. 914 funds tracked by Wall St. Rank hold HUM as of Q1 2022.

Strategy Asset Managers reported no remaining Humana position as of Q1 2022 after selling out during the quarter.
Strategy Asset Managers sold 1,429 Humana shares in Q1 2022, an estimated $663K.
Strategy Asset Managers first reported a position in Humana in Q3 2021 and held it in 2 quarters.
Strategy Asset Managers's Humana position peaked at $663K in Q4 2021.
914 funds tracked by Wall St. Rank held Humana as of Q1 2022.

Based on Strategy Asset Managers's 13F filing for Q1 2022, filed 11 Apr 2022.